News
mPharma backed by Growth Investment Partners to expand in Francophone West Africa
Health tech company mPharma has received a strategic investment from GIP Ghana, with more than half of the funding set for Francophone West Africa. The amount was not disclosed.
By Propel Africa · 2025-12-23
mPharma has received a strategic investment from GIP Ghana, Innovation Village reported on 23 December 2025. The amount was not disclosed. GIP Ghana is an investment platform set up by British International Investment.
What mPharma does
mPharma is a health tech company working on medicine affordability and access in Africa. Independent pharmacies join its Mutti brand network through an asset-light franchise model, supported by proprietary software for inventory, pricing and supply chain. The company was founded in 2013 and Kwesi Arhin is chief executive.
Where the money goes
The funding will extend the QualityRx franchise model into Togo and Benin and improve inventory efficiency across the pharmacy network. More than half of it is earmarked for Francophone West Africa. mPharma also plans to scale partnerships with pharmacies and healthcare providers.
Investor view
Jacob Kholi, Chief Executive and Investment Officer at GIP Ghana, said: "Our goal is to back enterprises that improve essential services for ordinary people."
At a glance
- Company: mPharma
- Raised: Not disclosed
- Round or Type: Strategic investment
- Investor: GIP Ghana (Growth Investment Partners)
- Founded: 2013
- Chief executive: Kwesi Arhin
- Markets: Ghana, with Togo and Benin next
- Key number: More than half of funding earmarked for Francophone West Africa